Journal of Andrology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published-Ahead-of-Print January 24, 2008, DOI:10.2164/jandrol.107.003616
Journal of Andrology, Vol. 29, No. 3, May/June 2008
Copyright © American Society of Andrology
DOI: 10.2164/jandrol.107.003616

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
29/3/330    most recent
Author Manuscript (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Valtonen-André, C.
Right arrow Articles by Lundwall, A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Valtonen-André, C.
Right arrow Articles by Lundwall, A.

Beta-Microseminoprotein in Serum Correlates With the Levels in Seminal Plasma of Young, Healthy Males

CAMILLA VALTONEN-ANDRÉ*, CHARLOTTA SäVBLOM*, PER FERNLUND*, HANS LILJA*,{dagger}, ALEKSANDER GIWERCMAN{ddagger} AND ÅKE LUNDWALL*

From the * Department of Laboratory Medicine, Division of Clinical Chemistry, Lund University, Malmö University Hospital, Malmö, Sweden; the {dagger} Department of Clinical Laboratories, Urology, and Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; and the {ddagger} Department of Clinical Sciences, Fertility Center, Lund University, Malmö University Hospital, Malmö, Sweden.

Correspondence to: Åke Lundwall, Wallenberglaboratory, 4th floor, University Hospital MAS, SE-205 02 Malmö, Sweden (e-mail: ake.lundwall{at}med.lu.se).


Beta-microseminoprotein (MSP) is one of the most abundant proteins secreted by the prostate gland. Because MSP is also synthesized in nonreproductive organs, the establishment of a solid relationship between the levels of MSP in serum and semen is crucial for future studies connecting MSP with aging or diseases of the prostate gland. We developed a specific, competitive, europium-based immunoassay to measure MSP in serum and seminal plasma. We also produced recombinant MSP in insect cells using baculo virus and purified it to homogeneity by a novel approach with ethanol extraction and gel filtration. The median values of MSP in 205 young men were 12 µg/L (2.5–97.5 percentile, 4.9–26 µg/L) in serum and 0.53 g/L (2.5–97.5 percentile, 0.13–2.0 g/L) or 1.8 mg (2.5–97.5 percentile, 0.32–6.6 mg) in seminal plasma. MSP in serum showed significant correlation to MSP in seminal plasma (r = .50, P < .001). Significant correlations were also found in seminal plasma between MSP and prostate-specific antigen (PSA) (r = .65, P < .001) and between MSP and Zn2+ (r = .54, P < .001). The yield of recombinant MSP in culture medium was 35 mg/L or higher, and recovery following ethanol extraction was 80%–90%. MSP in serum reflects the prostate secretion of MSP, and correlations were also found in seminal plasma between MSP and PSA and Zn2+. This suggests that MSP in serum can be used as a marker of prostate secretion, despite the contribution from extra prostatic tissues.

     Key words: Expression, immunoassay, prostate, purification, semen







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by The American Society of Andrology.